Lunesta, a sedative, also called a hypnotic, is used to treat insomnia and causes relaxation to help you fall asleep and stay asleep.
The suit settlement allows Lupin to sell its generic version of Lunesta under a license as soon as 30 November 2013.
Lupin is a led transnational pharmaceutical company that produces a range of generic and branded formulations and APIs for the developed and developing markets of the world.